ARCHIVES

In brief: ring appointed Associate Dean At UCSF; Univ. of Utah Forms Cell Signaling Center

This article is from The Cancer Letter archive.

Vol. 23 No. 30 | August 1, 1997

Download PDF Visit The Full Archive

Related Articles

Study Suggests Biomarker For Resistance to Tamoxifen

March 25, 2011

AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.

December 14, 2001

No Benefit For Cetuximab In Early-Stage Colon Cancer

December 25, 2009

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

CHOP Gets Concept Approval; DCT Release RFAs for Lung, Colon Drug Discovery Groups

October 24, 1986

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

June 12, 1992